Science 37 Holdings, Inc.
NASDAQ: SNCE0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- David Coman
- Employees
- 460
- Headquarters
- Research Triangle Park, United States
- IPO year
- 2020
- Market cap
- $34.7M
- Website
- https://www.science37.com
Loading SNCE…
Loading profile data…Frequently asked questions about SNCE
What does Science 37 Holdings, Inc. (SNCE) do?
Science 37 Holdings, Inc. specializes in providing innovative technology solutions to enable flexible and decentralized clinical trials. Their central platform facilitates modern, digital approaches to clinical research by bringing together all essential parties—including patients, trial investigators, nurses, coordinators, and sponsors—to strea...
Where does SNCE trade?
Science 37 Holdings, Inc. (SNCE) trades on the NASDAQ Global Market.
What sector is SNCE in?
Science 37 Holdings, Inc. (SNCE) operates in the Healthcare sector, specifically in the Medical - Healthcare Information Services industry.
Who is the CEO of Science 37 Holdings, Inc.?
David Coman is the chief executive officer of Science 37 Holdings, Inc. (SNCE).
Where is Science 37 Holdings, Inc. headquartered?
Science 37 Holdings, Inc. is headquartered in United States.
Does SNCE pay a dividend?
Science 37 Holdings, Inc. (SNCE) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SNCE go public?
Science 37 Holdings, Inc. (SNCE) completed its initial public offering in 2020.